Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Cortical Erosion in Early Stage Schizophrenia
NCT01339858Phase 4Completed
- Sponsor
- Indiana University
- Start
- May 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine in schizophrenia, schizoaffective disorder, schizophreniform disorder, psychotic disorder, sponsored by Indiana University. Started May 2011; status: completed.
02
Drugs
acetylcysteine
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorderpsychotic disorder
Beyond the preview
Go deeper on NCT01339858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01339858.